Replies to post #15 on Yunji Inc (YJ)

[TIMGZ]

MAY BE THE HYPE CAME FROM THE CONFERENCE CALL EARLIER TODAY*******

First Quarter 2023 Unaudited Financial Results

Total revenues were RMB178.7 million (US$26.0 million), compared with RMB342.6 million in the same period of 2022. This change was primarily due to the Company's continued strategy to refine its product selection across all categories and optimize its selection of suppliers and merchants, which had a near-term impact on sales.

Revenues from sales of merchandise were RMB143.0 million (US$20.8 million), compared with RMB290.5 million in the same period of 2022.
Revenues from the marketplace business were RMB32.9 million (US$4.8 million), compared with RMB47.4 million in the same period of 2022.
Other revenues were RMB2.8 million (US$0.4 million), compared with RMB4.7 million in the same period of 2022.

[TIMGZ]

KEEP EYE ON LXRX FOR NEXT WEEK, HOPEFULLY. JUST FDA APPROVED DRUG, DOING DILUTION WHICH WILL CLOSE LATEST MONDAY AND PARTY BEGINS